{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:42:51Z","timestamp":1789544571247,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Instrumented posterior lumbar fusion (IPLF) with and without transforaminal interbody fusion (TLIF) is a common treatment for low back pain when conservative interventions have failed. Certain patient comorbidities and lifestyle risk factors, such as obesity and smoking, are known to negatively affect these procedures. An advanced cellular bone allograft (CBA) with viable osteogenic cells (V-CBA) has demonstrated high fusion rates, but the rates for patients with severe and\/or multiple comorbidities remain understudied. The purpose of this study was to assess fusion outcomes in patients undergoing IPLF\/TLIF using V-CBA with baseline comorbidities and lifestyle risk factors known to negatively affect bone fusion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective study of de-identified data from consecutive patients at an academic medical center who underwent IPLF procedures with or without TLIF, and with V-CBA. Baseline patient and procedure characteristics were assessed. Radiological outcomes included fusion rates per the Lenke scale. Patient-reported clinical outcomes were evaluated via the Oswestry Disability Index (ODI) and Visual Analog Scale (VAS) for back and leg pain. Operating room (OR) times and intraoperative blood loss rates were also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data from 96 patients were assessed with a total of 222 levels treated overall (mean: 2.3 levels) and a median follow-up time of 16\u2009months (range: 6 to 45\u2009months). Successful fusion (Lenke A or B) was reported for 88 of 96 patients (91.7%) overall, including in all IPLF-only patients. Of 22 patients with diabetes in the IPLF+TLIF group, fusion was reported in 20 patients (90.9%). In IPLF+TLIF patients currently using tobacco (<jats:italic>n<\/jats:italic>\u00a0=\u200919), fusion was reported in 16 patients (84.3%), while in those with a history of tobacco use (<jats:italic>n<\/jats:italic>\u00a0=\u200953), fusion was observed in 48 patients (90.6%). Successful fusion was reported in all 6 patients overall with previous pseudarthrosis at the same level. Mean postoperative ODI and VAS scores were significantly reduced versus preoperative ratings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results of this study suggest that V-CBA consistently yields successful fusion and significant decreases in patient-reported ODI and VAS, despite patient comorbidities and lifestyle risk factors that are known to negatively affect such bony healing.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04584-z","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T09:02:52Z","timestamp":1629190972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Lumbar spine fusion outcomes using a cellular bone allograft with lineage-committed bone-forming cells in 96 patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Hossein","family":"Elgafy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Wetzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Gillette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Semaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Balboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Mierzwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie B.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Dorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"issue":"1","key":"4584_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/2192568217696688","volume":"8","author":"Z Buser","year":"2018","unstructured":"Buser Z, Ortega B, D\u2019Oro A, Pannell W, Cohen JR, Wang J, et al. Spine degenerative conditions and their treatments: national trends in the United States of America. Global Spine J. 2018;8(1):57\u201367. https:\/\/doi.org\/10.1177\/2192568217696688.","journal-title":"Global Spine J"},{"issue":"2","key":"4584_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/2192568218790557","volume":"9","author":"C Saifi","year":"2019","unstructured":"Saifi C, Cazzulino A, Laratta J, Save AV, Shillingford JN, Louie PK, et al. Utilization and economic impact of posterolateral fusion and posterior\/Transforaminal lumbar interbody fusion surgeries in the United States. Global Spine J. 2019;9(2):185\u201390. https:\/\/doi.org\/10.1177\/2192568218790557.","journal-title":"Global Spine J"},{"issue":"8","key":"4584_CR3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1177\/2192568219889360","volume":"10","author":"ID Kaye","year":"2019","unstructured":"Kaye ID, Fang T, Wagner SC, Butler JS, Sebastian A, Morrissey PB, et al. A comparison of revision rates and patient-reported outcomes for a 2-level posterolateral fusion augmented with single versus 2-level Transforaminal lumbar interbody fusion. Global Spine J. 2019;10(8):958\u201363. https:\/\/doi.org\/10.1177\/2192568219889360.","journal-title":"Global Spine J"},{"key":"4584_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clineuro.2016.08.017","volume":"150","author":"AA Ghasemi","year":"2016","unstructured":"Ghasemi AA. Transforaminal lumbar interbody fusion versus instrumented posterolateral fusion in degenerative spondylolisthesis: an attempt to evaluate the superiority of one method over the other. Clin Neurol Neurosurg. 2016;150:1\u20135. https:\/\/doi.org\/10.1016\/j.clineuro.2016.08.017.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"4584_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.4184\/asj.2018.12.2.372","volume":"12","author":"JR Daniell","year":"2018","unstructured":"Daniell JR, Osti OL. Failed Back surgery syndrome: a review article. Asian Spine J. 2018;12(2):372\u20139. https:\/\/doi.org\/10.4184\/asj.2018.12.2.372.","journal-title":"Asian Spine J"},{"issue":"9","key":"4584_CR6","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1016\/j.spinee.2019.05.571","volume":"19","author":"C Gatot","year":"2019","unstructured":"Gatot C, Liow MHL, Mohan N, Goh GS, Chen J, Yue W-M. P146. Smoking is associated with poorer fusion, functional outcomes and lower satisfaction in non-diabetic patients undergoing single-level transforaminal lumbar interbody fusion. Spine J. 2019;19(9):S225\u20136. https:\/\/doi.org\/10.1016\/j.spinee.2019.05.571.","journal-title":"Spine J"},{"issue":"6","key":"4584_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1302\/2046-3758.26.2000142","volume":"2","author":"R Patel","year":"2013","unstructured":"Patel R, Wilson R, Patel P, Palmer R. The effect of smoking on bone healing: a systematic review. Bone Joint Res. 2013;2(6):102\u201311. https:\/\/doi.org\/10.1302\/2046-3758.26.2000142.","journal-title":"Bone Joint Res"},{"issue":"1","key":"4584_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5435\/00124635-200501000-00010","volume":"13","author":"SN Khan","year":"2005","unstructured":"Khan SN, Cammisa FP Jr, Sandhu HS, Diwan AD, Girardi FP, Lane JM. The biology of bone grafting. J Am Acad Orthop Surg. 2005;13(1):77\u201386. https:\/\/doi.org\/10.5435\/00124635-200501000-00010.","journal-title":"J Am Acad Orthop Surg"},{"issue":"3","key":"4584_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/00005131-198909000-00002","volume":"3","author":"EM Younger","year":"1989","unstructured":"Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma. 1989;3(3):192\u20135. https:\/\/doi.org\/10.1097\/00005131-198909000-00002.","journal-title":"J Orthop Trauma"},{"issue":"1","key":"4584_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s13018-019-1424-2","volume":"14","author":"JF Hall","year":"2019","unstructured":"Hall JF, McLean JB, Jones SM, Moore MA, Nicholson MD, Dorsch KA. Multilevel instrumented posterolateral lumbar spine fusion with an allogeneic cellular bone graft. J Orthop Surg Res. 2019;14(1):372. https:\/\/doi.org\/10.1186\/s13018-019-1424-2.","journal-title":"J Orthop Surg Res"},{"key":"4584_CR11","volume-title":"Technical Monograph: ViviGen\u00ae Cellular Bone Matrix","author":"LifeNet Health\u00ae","year":"2017","unstructured":"LifeNet Health\u00ae. Technical Monograph: ViviGen\u00ae Cellular Bone Matrix. 2017. Document #68\u201340-254.00. Available from: https:\/\/www.lifenethealth.org\/sites\/default\/files\/files\/68-40-254%20Technical%20Monograph.pdf."},{"issue":"2","key":"4584_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1563\/780.1","volume":"32","author":"JW Turonis","year":"2006","unstructured":"Turonis JW, McPherson JC III, Cuenin MF, Hokett SD, Peacock ME, Sharawy M. The effect of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium. J Oral Implantol. 2006;32(2):55\u201362. https:\/\/doi.org\/10.1563\/780.1.","journal-title":"J Oral Implantol"},{"issue":"11","key":"4584_CR13","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1902\/jop.1997.68.11.1085","volume":"68","author":"M Zhang","year":"1997","unstructured":"Zhang M, Powers RM Jr, Wolfinbarger L Jr. Effect(s) of the demineralization process on the osteoinductivity of demineralized bone matrix. J Periodontol. 1997;68(11):1085\u201392. https:\/\/doi.org\/10.1902\/jop.1997.68.11.1085.","journal-title":"J Periodontol"},{"key":"4584_CR14","unstructured":"Roukis TS, Wetzell B, McLean JB, Dorsch KA, Moore MA. A Retrospective Comparison of Clinical and Patient-Reported Outcomes in Foot and Ankle Arthrodesis Procedures Using Two Cellular Bone Allografts. Clin Res Foot Ankle. 2020;8(4):E1\u20136. Available from: https:\/\/www.omicsonline.org\/open-access\/a-retrospective-comparison-of-clinical-and-patientreported-outcomes-in-foot-and-ankle-arthrodesis-procedures-using-two-c.pdf."},{"key":"4584_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.22203\/eCM.v023a02","volume":"23","author":"E Birmingham","year":"2012","unstructured":"Birmingham E, Niebur G, McHugh PE. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cells Mater. 2012;23:13\u201327. https:\/\/doi.org\/10.22203\/eCM.v023a02.","journal-title":"Eur Cells Mater"},{"issue":"32","key":"4584_CR16","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1016\/j.biomaterials.2011.07.041","volume":"32","author":"S Ghanaati","year":"2011","unstructured":"Ghanaati S, Unger RE, Webber MJ, Barbeck M, Orth C, Kirkpatrick JA, et al. Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells. Biomaterials. 2011;32(32):8150\u201360. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.07.041.","journal-title":"Biomaterials."},{"issue":"10","key":"4584_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/term.392","volume":"5","author":"JC Reichert","year":"2011","unstructured":"Reichert JC, Quent VM, Noth U, Hutmacher DW. Ovine cortical osteoblasts outperform bone marrow cells in an ectopic bone assay. J Tissue Eng Regen Med. 2011;5(10):831\u201344. https:\/\/doi.org\/10.1002\/term.392.","journal-title":"J Tissue Eng Regen Med"},{"issue":"2","key":"4584_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.biomaterials.2009.09.038","volume":"31","author":"F Tortelli","year":"2010","unstructured":"Tortelli F, Tasso R, Loiacono F, Cancedda R. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials. 2010;31(2):242\u20139. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.09.038.","journal-title":"Biomaterials."},{"issue":"22","key":"4584_CR19","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1097\/00007632-200011150-00017","volume":"25","author":"JC Fairbank","year":"2000","unstructured":"Fairbank JC, Pynsent PB. The Oswestry disability index. Spine (Phila Pa 1976). 2000;25(22):2940\u201353. https:\/\/doi.org\/10.1097\/00007632-200011150-00017.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"2","key":"4584_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0039-6109(05)70381-9","volume":"79","author":"J Katz","year":"1999","unstructured":"Katz J, Melzack R. Measurement of pain. Surg Clin North Am. 1999;79(2):231\u201352. https:\/\/doi.org\/10.1016\/S0039-6109(05)70381-9.","journal-title":"Surg Clin North Am"},{"key":"4584_CR21","doi-asserted-by":"publisher","unstructured":"Elgafy H, Lempert N, Stirton J, Zak P, Semaan H. Pedicle Screw Track Augmentation With Fibular Allograft for Significant Bone Loss in Revision Fixation. Global Spine J. 2021. https:\/\/doi.org\/10.1177\/2192568221997076.","DOI":"10.1177\/2192568221997076"},{"issue":"4","key":"4584_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00002517-199212000-00008","volume":"5","author":"LG Lenke","year":"1992","unstructured":"Lenke LG, Bridwell KH, Bullis D, Betz RR, Baldus C, Schoenecker PL. Results of in situ fusion for isthmic spondylolisthesis. J Spinal Disord. 1992;5(4):433\u201342. https:\/\/doi.org\/10.1097\/00002517-199212000-00008.","journal-title":"J Spinal Disord"},{"key":"4584_CR23","doi-asserted-by":"publisher","unstructured":"Moran T, Sequeira S, Cooper M, Park J. A Retrospective Analysis of Outcomes from Foot and Ankle Arthrodesis and Open Reduction and Internal Fixation using Cellular Bone Allograft Augmentation. Foot Ankle Spec. 2020. https:\/\/doi.org\/10.1177\/1938640020952301.","DOI":"10.1177\/1938640020952301"},{"issue":"6","key":"4584_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/01.BRS.0000116588.17129.B9","volume":"29","author":"FP Cammisa Jr","year":"2004","unstructured":"Cammisa FP Jr, Lowery G, Garfin SR, et al. Two-year fusion rate equivalency between Grafton\u00ae DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient. Spine (Phila Pa 1976). 2004;29(6):660\u20136. https:\/\/doi.org\/10.1097\/01.BRS.0000116588.17129.B9.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"9","key":"4584_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/01.brs.0000215048.51237.3c","volume":"31","author":"DK Sengupta","year":"2006","unstructured":"Sengupta DK, Truumees E, Patel CK, Kazmierczak C, Hughes B, Elders G, et al. Outcome of local bone versus autogenous iliac crest bone graft in the instrumented posterolateral fusion of the lumbar spine. Spine (Phila Pa 1976). 2006;31(9):985\u201391. https:\/\/doi.org\/10.1097\/01.brs.0000215048.51237.3c.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"26","key":"4584_CR26","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1097\/BRS.0b013e318190705d","volume":"33","author":"SD Glassman","year":"2008","unstructured":"Glassman SD, Carreon LY, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, et al. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age. Spine (Phila Pa 1976). 2008;33(26):2843\u20139. https:\/\/doi.org\/10.1097\/BRS.0b013e318190705d.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"26","key":"4584_CR27","doi-asserted-by":"publisher","first-page":"E1744","DOI":"10.1097\/BRS.0b013e31821f50de","volume":"36","author":"S Ohtori","year":"2011","unstructured":"Ohtori S, Koshi T, Suzuki M, Takaso M, Yamashita M, Yamauchi K, et al. Uni-and bilateral instrumented posterolateral fusion of the lumbar spine with local bone grafting: a prospective study with a 2-year follow-up. Spine (Phila Pa 1976). 2011;36(26):E1744\u20138. https:\/\/doi.org\/10.1097\/BRS.0b013e31821f50de.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"4584_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jocn.2008.02.009","volume":"16","author":"S-C Lee","year":"2009","unstructured":"Lee S-C, Chen J-F, Wu C-T, Lee S-T. In situ local autograft for instrumented lower lumbar or lumbosacral posterolateral fusion. J Clin Neurosci. 2009;16(1):37\u201343. https:\/\/doi.org\/10.1016\/j.jocn.2008.02.009.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"4584_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-016-0501-z","volume":"12","author":"DD Lee","year":"2017","unstructured":"Lee DD, Kim JY. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2. J Orthop Surg Res. 2017;12(1):1\u20138.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"4584_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14444\/6007","volume":"13","author":"SC Overley","year":"2019","unstructured":"Overley SC, McAnany SJ, Anwar MA, et al. Predictive factors and rates of fusion in minimally invasive Transforaminal lumbar interbody fusion utilizing rhBMP-2 or mesenchymal stem cells. Int J Spine Surg. 2019;13(1):46\u201352. https:\/\/doi.org\/10.14444\/6007.","journal-title":"Int J Spine Surg"},{"issue":"6","key":"4584_CR31","doi-asserted-by":"publisher","first-page":"e97049","DOI":"10.1371\/journal.pone.0097049","volume":"9","author":"H Zhang","year":"2014","unstructured":"Zhang H, Wang F, Ding L, Zhang Z, Sun D, Feng X, et al. A meta analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graft. PLoS One. 2014;9(6):e97049. https:\/\/doi.org\/10.1371\/journal.pone.0097049.","journal-title":"PLoS One"},{"issue":"1","key":"4584_CR32","first-page":"E28","volume":"29","author":"MD Alvin","year":"2016","unstructured":"Alvin MD, Derakhshan A, Lubelski D, et al. Cost-utility analysis of 1-and 2-level dorsal lumbar fusions with and without recombinant human bone morphogenic protein-2 at 1-year follow-up. J Spinal Disord Tech. 2016;29(1):E28\u201333.","journal-title":"J Spinal Disord Tech"},{"issue":"14","key":"4584_CR33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/BRS.0000000000003442","volume":"45","author":"A Jain","year":"2020","unstructured":"Jain A, Yeramaneni S, Kebaish KM, Raad M, Gum JL, Klineberg EO, et al. Cost-utility analysis of rhBMP-2 use in adult spinal deformity surgery. Spine (Phila Pa 1976). 2020;45(14):1009\u201315. https:\/\/doi.org\/10.1097\/BRS.0000000000003442.","journal-title":"Spine (Phila Pa 1976)"},{"issue":"Suppl 5","key":"4584_CR34","doi-asserted-by":"publisher","first-page":"S343","DOI":"10.4103\/2152-7806.114813","volume":"4","author":"NE Epstein","year":"2013","unstructured":"Epstein NE. Complications due to the use of BMP\/INFUSE in spine surgery: the evidence continues to mount. Surg Neurol Int. 2013;4(Suppl 5):S343\u201352. https:\/\/doi.org\/10.4103\/2152-7806.114813.","journal-title":"Surg Neurol Int"},{"issue":"12","key":"4584_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.7326\/0003-4819-158-12-201306180-00006","volume":"158","author":"R Fu","year":"2013","unstructured":"Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, et al. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann Intern Med. 2013;158(12):890\u2013902. https:\/\/doi.org\/10.7326\/0003-4819-158-12-201306180-00006.","journal-title":"Ann Intern Med"},{"issue":"6","key":"4584_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00701-017-3078-3","volume":"159","author":"M Vazan","year":"2017","unstructured":"Vazan M, Gempt J, Meyer B, Buchmann N, Ryang Y-M. Minimally invasive transforaminal lumbar interbody fusion versus open transforaminal lumbar interbody fusion: a technical description and review of the literature. Acta Neurochir. 2017;159(6):1137\u201346. https:\/\/doi.org\/10.1007\/s00701-017-3078-3.","journal-title":"Acta Neurochir"},{"issue":"4","key":"4584_CR37","doi-asserted-by":"publisher","DOI":"10.3171\/2015.7.FOCUS15292","volume":"39","author":"DS Chun","year":"2015","unstructured":"Chun DS, Baker KC, Hsu WK. Lumbar pseudarthrosis: a review of current diagnosis and treatment. Neurosurg Focus. 2015;39(4):E10. https:\/\/doi.org\/10.3171\/2015.7.FOCUS15292.","journal-title":"Neurosurg Focus"},{"issue":"3","key":"4584_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.21037\/jss.2019.08.09","volume":"5","author":"JP Kelly","year":"2019","unstructured":"Kelly JP, Alcala-Marquez C, Dawson JM, Mehbod AA, Pinto MR. Treatment of degenerative spondylolisthesis by instrumented posterolateral versus instrumented posterolateral with transforaminal lumbar interbody single-level fusion. J Spine Surg. 2019;5(3):351\u20137. https:\/\/doi.org\/10.21037\/jss.2019.08.09.","journal-title":"J Spine Surg"},{"issue":"4","key":"4584_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jamcollsurg.2014.12.040","volume":"220","author":"BJ Daley","year":"2015","unstructured":"Daley BJ, Cecil W, Clarke PC, Cofer JB, Guillamondegui OD. How slow is too slow? Correlation of operative time to complications: an analysis from the Tennessee surgical quality collaborative. J Am Coll Surg. 2015;220(4):550\u20138. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2014.12.040.","journal-title":"J Am Coll Surg"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04584-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04584-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04584-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T09:07:32Z","timestamp":1629191252000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04584-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4584"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04584-z","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for this study was approved by the first author\u2019s (HE) institutional review board and written informed consent was obtained from all patients. Patient data for this study were considered de-identified in accordance with the HIPAA Privacy Rule described in Title 45 of the US Code of Federal Regulations Part 164.506(d)(2)(ii)(B).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HE received research funding for this work from LifeNet Health\u00ae, the non-profit organization which processes ViviGen, and which played no role in the collection of data or the independent assessments of fusion. BW, JBM, KD, and MAM are employees of LifeNet Health\u00ae and participated in the analysis and interpretation of the data, and in the writing of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"699"}}